Mazzola Michele, Giani Alessandro, Crippa Jacopo, Morini Lorenzo, Zironda Andrea, Bertoglio Camillo Leonardo, De Martini Paolo, Magistro Carmelo, Ferrari Giovanni
Division of Minimally-Invasive Surgical Oncology, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore, 3 20162 Milan, Italy.
Indian J Surg Oncol. 2021 Dec;12(4):688-698. doi: 10.1007/s13193-021-01422-5. Epub 2021 Aug 16.
Despite recent advances in minimally invasive pancreatic surgery, laparoscopic pancreaticoduodenectomy (LPD) has not reach a wide diffusion, mainly due to its technical difficulty. Considering its potential benefits, efforts should be made to improve its adoption. Between January 2017 and March 2020, LPD was offered as the primary approach to all the patients with an indication to pancreaticoduodenectomy. The overall cohort was divided into two groups: the early group (EG), including the first 30 cases, and the late group (LG), with the remaining patients. Perioperative data were gathered from a prospectively collected database and retrospectively analyzed, comparing the short-term outcomes of the two groups. In the study period, 52 patients underwent LPD. Among these, 88.4% patients were preoperatively diagnosed with a malignant disease. No difference was found between EG and LG in terms of baseline characteristics, mean operative time, estimated blood loss, and conversion to laparotomy. The overall complication rate was 57.7%, with severe complications occurring in 14 patients (26.9%). Two patients (3.8%) deceased within 90 days from the operation. No difference was found between EG and LG regarding postoperative outcomes. Among oncological patients, 86.7% received an R0 resection, and 13.3% had an R1 resection. The EG and LG did not differ in terms of oncological radicality and number of lymph nodes retrieved. LPD is a reproducible surgical technique that may provide acceptable results in both early and late phase of experience, when performed by surgical team with broad background in laparoscopic surgery.
尽管微创胰腺手术近年来取得了进展,但腹腔镜胰十二指肠切除术(LPD)尚未广泛普及,主要是由于其技术难度较大。考虑到其潜在益处,应努力提高其应用率。2017年1月至2020年3月期间,LPD被作为所有有胰十二指肠切除术指征患者的主要手术方式。整个队列分为两组:早期组(EG),包括前30例病例;晚期组(LG),包括其余患者。围手术期数据从前瞻性收集的数据库中获取并进行回顾性分析,比较两组的短期结果。在研究期间,52例患者接受了LPD。其中,88.4%的患者术前被诊断为恶性疾病。在基线特征、平均手术时间、估计失血量和中转开腹方面,EG组和LG组之间未发现差异。总体并发症发生率为57.7%,14例患者(26.9%)发生了严重并发症。两名患者(3.8%)在术后90天内死亡。EG组和LG组在术后结果方面未发现差异。在肿瘤患者中,86.7%的患者实现了R0切除,13.3%的患者为R1切除。EG组和LG组在肿瘤根治性和获取的淋巴结数量方面没有差异。LPD是一种可重复的手术技术,由具有广泛腹腔镜手术背景的手术团队实施时,在早期和晚期经验中都可能提供可接受的结果。